WESTERN STATES NODE


WESTERN STATES NODE

Principal Investigators:
James L. Sorensen, PhD [email]
Department of Psychiatry
University of California, San Francisco
1001 Potrero Ave.
San Francisco, CA 94110

Dennis McCarty, PhD [email]
Department of Public Health & Preventive Medicine
Oregon Health and Science University
3181 SW Sam Jackson Park Rd., CB 669
Portland, OR 97239

Find Node Publications
Node Facebook page
Node Twitter feed

Node web site
NIDA web site

The Western States Node was established in 2010, combining into a single node both the Regional Research and Training Centers and the Community Treatment Programs of the original CTN nodes in Oregon/Hawaii and [Northern] California/Arizona, with an additional CTP from Colorado.


WESTERN STATES NODE PROTOCOL INVOLVEMENT

CTN-0002 Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification
CTN-0003 Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Taper Schedules
CTN-0005 MI (Motivational Interviewing) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse
CTN-0008 Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating Diffusion of Innovation
CTN-0012 Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs
CTN-0014 Brief Strategic Family Therapy for Adolescent Drug Abusers
CTN-0014-A-1 Mediators and Moderators of Brief Strategic Family Therapy (BSFT) for Adolescent Drug Use
CTN-0017 HIV and HCV Intervention in Drug Treatment Settings
CTN-0018 Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment
CTN-0020 Job Seekers Training for Patients with Drug Dependence
CTN-0021 Motivational Enhancement Treatment to Improve Treatment Engagement and Outcome for Spanish-Speaking Individuals Seeking Treatment for Substance Abuse
CTN-0027 Starting Treatment with Agonist Replacement Therapies (START)
CTN-0027-A-1 START Pharmacogenetics: Exploratory Genetic Studies in Starting Treatment with Agonist Replacement Therapies
CTN-0027-A-2 Retention of Suboxone Patients in START: Perspectives of Providers and Patients
CTN-0029 Attention Deficit Hyperactivity Disorder (ADHD) in Adult Smokers
CTN-0030

Prescription Opioid Addiction Treatment Study (POATS)

CTN-0030-A-1 Collection of Economic Data for the Prescription Opioid Addiction Treatment Study
CTN-0031 Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement
CTN-0031-A-1 An Evaluation of Neurocognitive Function, Oxidative Damage, and Their Association with Treatment Outcomes in Methamphetamine and Cocaine Abusers
CTN-0031-A-3 Organizational and Practitioner Influences on Implementation of STAGE-12
CTN-0032-A-1 Economic Analysis of HIV Rapid Testing in Drug Abuse Treatment Programs
CTN-0033-Ot-1 Methamphetamine Use Among American Indians
CTN-0033-Ot-5 The Choctaw Nation Methamphetamine Data Needs Project
CTN-0035-Ot Access to HIV and Hepatitis Screening and Care Among Ethnic Minority Drug Users In and Out of Drug Treatment
CTN-0038-Ot Barriers to Substance Abuse Treatment Among Asian Americans and Pacific Islanders
CTN-0043-S Substance Abuse Treatment Outcomes in Racial/Ethnic Minority Populations
CTN-0044 Web-Delivery of Evidence-Based, Psychosocial Treatment for Substance Use Disorders
CTN-0044-A-2 Acceptability of a Web-delivered, Evidence-based, Psychosocial Intervention among Individuals with Substance Use Disorders who Identify as American Indian/Alaska Native
CTN-0044-A-3 Web-Tx Organizational and Practitioner Follow-Up
CTN-0046 Smoking Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking Cessation and Stimulant Treatment on Stimulant Dependence
CTN-0046-A-1 Site Influences on Treatment Effects - Smoking Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking Cessation and Stimulant Treatment on Stimulant-Dependent Outcome
CTN-0048 Cocaine Use Reduction with Buprenorphine (CURB)
CTN-0049 Project HOPE: Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
CTN-0050 Long Term Follow-Up of START Patients
CTN-0055 Comparing Treatments for HIV-Positive Opioid Users in an Integrated Care Effectiveness Study (CHOICES)

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 3/2014 -- http://ctndisseminationlibrary.org/nodes/wsnode.htm
info@ctndisseminationlibrary.org